tiprankstipranks
Trending News
More News >
Thomson Medical Group Ltd. (SG:A50)
:A50
Singapore Market
Advertisement

Thomson Medical Group Ltd. (A50) Ratios

Compare
7 Followers

Thomson Medical Group Ltd. Ratios

SG:A50's free cash flow for Q4 2024 was S$0.53. For the 2024 fiscal year, SG:A50's free cash flow was decreased by S$ and operating cash flow was S$-0.02. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.19 1.08 3.67 0.95 3.01
Quick Ratio
0.67 0.72 2.91 0.66 1.80
Cash Ratio
0.46 0.57 2.39 0.48 0.85
Solvency Ratio
-0.02 0.03 0.07 0.09 0.03
Operating Cash Flow Ratio
0.22 0.29 0.74 0.27 0.74
Short-Term Operating Cash Flow Coverage
0.37 0.44 7.30 0.41 190.82
Net Current Asset Value
S$ -916.61MS$ -915.61MS$ -431.45MS$ -436.05MS$ -469.28M
Leverage Ratios
Debt-to-Assets Ratio
0.63 0.62 0.53 0.47 0.49
Debt-to-Equity Ratio
2.38 2.24 1.53 1.21 1.29
Debt-to-Capital Ratio
0.70 0.69 0.60 0.55 0.56
Long-Term Debt-to-Capital Ratio
0.67 0.65 0.60 0.43 0.56
Financial Leverage Ratio
3.79 3.62 2.90 2.57 2.62
Debt Service Coverage Ratio
0.22 0.41 2.17 0.40 2.10
Interest Coverage Ratio
0.00 1.43 2.70 3.91 2.07
Debt to Market Cap
0.69 0.84 0.48 0.30 0.27
Interest Debt Per Share
0.04 0.04 0.03 0.03 0.02
Net Debt to EBITDA
23.90 8.75 4.46 4.35 9.41
Profitability Margins
Gross Profit Margin
48.45%78.43%83.31%83.42%48.26%
EBIT Margin
3.49%22.98%24.09%27.81%20.30%
EBITDA Margin
9.16%31.06%30.02%33.18%24.77%
Operating Profit Margin
3.49%20.94%23.12%27.51%20.30%
Pretax Profit Margin
-8.92%8.30%15.52%20.77%10.89%
Net Profit Margin
-10.44%4.03%10.27%16.11%5.92%
Continuous Operations Profit Margin
-10.31%5.19%11.54%17.56%7.03%
Net Income Per EBT
117.13%48.56%66.22%77.58%54.38%
EBT Per EBIT
-255.36%39.65%67.11%75.48%53.64%
Return on Assets (ROA)
-2.67%0.78%2.52%3.94%1.11%
Return on Equity (ROE)
-9.69%2.83%7.32%10.11%2.91%
Return on Capital Employed (ROCE)
1.05%4.85%6.20%8.94%4.06%
Return on Invested Capital (ROIC)
1.09%2.68%4.54%6.16%2.61%
Return on Tangible Assets
-4.96%1.55%3.78%6.10%1.78%
Earnings Yield
-2.95%1.07%2.34%2.57%0.63%
Efficiency Ratios
Receivables Turnover
10.55 10.84 6.46 6.34 19.23
Payables Turnover
13.32 5.08 4.67 4.15 13.02
Inventory Turnover
1.69 0.71 0.65 0.56 1.23
Fixed Asset Turnover
0.91 0.72 0.83 0.73 0.54
Asset Turnover
0.26 0.19 0.25 0.24 0.19
Working Capital Turnover Ratio
8.97 2.03 2.35 4.47 1.27
Cash Conversion Cycle
222.99 473.36 542.65 621.50 287.03
Days of Sales Outstanding
34.61 33.66 56.46 57.53 18.99
Days of Inventory Outstanding
215.78 511.61 564.40 651.93 296.08
Days of Payables Outstanding
27.39 71.91 78.21 87.96 28.04
Operating Cycle
250.39 545.27 620.86 709.46 315.07
Cash Flow Ratios
Operating Cash Flow Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
0.63 0.64 0.86 0.70 0.39
Dividend Paid and CapEx Coverage Ratio
2.68 2.04 2.05 2.89 1.64
Capital Expenditure Coverage Ratio
2.68 2.75 6.93 3.30 1.64
Operating Cash Flow Coverage Ratio
0.05 0.07 0.12 0.14 0.10
Operating Cash Flow to Sales Ratio
0.13 0.24 0.25 0.28 0.25
Free Cash Flow Yield
2.35%4.01%4.86%3.10%1.05%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-33.94 93.39 42.68 38.85 159.85
Price-to-Sales (P/S) Ratio
3.54 3.76 4.38 6.26 9.47
Price-to-Book (P/B) Ratio
3.43 2.65 3.12 3.93 4.65
Price-to-Free Cash Flow (P/FCF) Ratio
42.60 24.95 20.58 32.30 94.97
Price-to-Operating Cash Flow Ratio
26.71 15.86 17.61 22.51 37.15
Price-to-Earnings Growth (PEG) Ratio
0.34 -1.45 -1.42 0.13 -1.41
Price-to-Fair Value
3.43 2.65 3.12 3.93 4.65
Enterprise Value Multiple
62.56 20.87 19.07 23.21 47.63
Enterprise Value
2.61B 2.28B 2.04B 2.57B 2.84B
EV to EBITDA
62.56 20.87 19.07 23.21 47.63
EV to Sales
5.73 6.48 5.72 7.70 11.80
EV to Free Cash Flow
68.94 42.95 26.86 39.74 118.36
EV to Operating Cash Flow
43.18 27.31 22.98 27.69 46.30
Tangible Book Value Per Share
-0.01 -0.01 <0.01 <0.01 <0.01
Shareholders’ Equity Per Share
0.02 0.02 0.02 0.02 0.02
Tax and Other Ratios
Effective Tax Rate
-0.16 0.38 0.26 0.15 0.35
Revenue Per Share
0.02 0.01 0.01 0.01 <0.01
Net Income Per Share
>-0.01 <0.01 <0.01 <0.01 <0.01
Tax Burden
1.17 0.49 0.66 0.78 0.54
Interest Burden
-2.55 0.36 0.64 0.75 0.54
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.00 >-0.01 >-0.01 0.00 0.00
Stock-Based Compensation to Revenue
>-0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
-1.27 2.86 1.60 1.34 4.30
Currency in SGD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis